As has been reported in ET, we found that CALR versus JAK2 mutations were significantly associated with lower hemoglobin level and higher platelet count and, although not significant, probably due to the limited series, to younger age at diagnosis [6], [7]. The gene discussed is CALR; the disease is essential thrombocythemia.